Published June 1, 2026 1 min read

# Welcome to the APOE4 Monthly Digest

## The short version

This digest is a dated reading list for APOE4 carriers, not a dump of every Alzheimer's headline. Each note gives the real numbers, the primary source, and what the result does not prove. If you are new, start with the primer on what APOE4 means.

By the OutliveAPOE4 editorial team. [How we research & source](/methodology).

Welcome. The **Monthly Digest** is a running, dated stream that mixes two things: short study-and-development summaries (a 1 to 2 minute read each), and occasional longer, newsletter-style issues. Both are for people who carry the APOE4 gene, whether you were just told you carry a copy or you have been managing this for years.

If **APOE4** itself is unfamiliar, the [plain-language primer](/topics/what-is-apoe4) is the prerequisite. When a digest cites a relative-risk headline, the [study-reading guide](/topics/reading-a-study-like-a-skeptic) shows how to check the denominator; the [Start Here guide](/start-here) turns that context into a measured next step.

What you can expect:

-   **Plain language with the actual numbers.** When we cover a study, we try to give you the real figures, what they mean for a carrier specifically (absolute risk, not just “doubles”), and the honest caveats, not a vague “linked to.”
-   **Source links.** Every summary points back to the primary material.
-   **Signal over noise.** We don’t try to cover everything, just what is genuinely useful for carriers. An example of the bar: a drug’s ARIA risk (amyloid-related imaging abnormalities: brain swelling or small bleeds seen on some anti-amyloid treatments) broken out *by APOE genotype*, not just “increased risk.”

If you’d rather get these in your inbox, subscribe to the newsletter and we’ll send the best of the digest periodically. And if you’re brand new to all this, start with our [Start Here guide](/start-here).

## Related deep dives

-   [What is APOE4? A plain-language primer APOE4 is the most common genetic risk factor for late-onset Alzheimer’s. What the gene does, what carrying one or two copies means, and the crucial things it does not mean.](/topics/what-is-apoe4)
-   [APOE4 myths vs. facts Carrier forums and headlines spread a lot of half-truths about APOE4. The recurring ones worth correcting, and what the evidence actually supports.](/topics/apoe4-myths-vs-facts)
-   [Reading a study like a skeptic: a carrier’s media-literacy guide APOE4 headlines swing from "cure" to "doom" weekly. A practical toolkit for reading health studies and news so you can tell real signal from hype, and act on the right things.](/topics/reading-a-study-like-a-skeptic)